Home Tags Initial Public Offering

Tag: Initial Public Offering

A company called Zoom Technologies is surging because people think it is Zoom Video Communications

Zoom Video Communications is going public on Thursday at a valuation of more than $9 billion, and investors are buying up Zoom Technologies.

Zoom — a profitable unicorn — is set to make its stock-market debut

Zoom Video Communications Inc. is set to begin trading on the Nasdaq on Thursday under the ticker ZM.

Here comes Pinterest …

Pinterest is set to begin trading Thursday on the New York Stock Exchange under the ticker PINS.
PagerDuty CEO Jennifer Tejada

Here comes PagerDuty, the 3rd unicorn IPO of the year …

Cloud-company PagerDuty will be the latest tech "unicorn" to go public. It will have a $1.8 billion valuation at its IPO price of $24 a share.
FILE PHOTO: A Pinterest banner hangs on the facade of the NYSE in New York

Pinterest prices its IPO at a price tag of $11.3 billion — below where it was last valued

The social-media company set the range of its IPO at between $15 and $17 a share, giving it a maximum valuation of $11.3 billion.
FILE PHOTO - Lee Olesky, co-founder and CEO of Tradeweb Markets LLC., speaks at the Sandler O'Neill + Partners Global Exchange and Brokerage Conference in New York

Here comes Tradeweb, the 3rd mega IPO of 2019 …

Tradeweb to raise over $1 billion in third mega-IPO of 2019. The company will have a valuation of $6 billion.

Here comes Gossamer Bio…

Gossamer Bio priced its initial public offering at $16 a share Thursday evening, raising about $276 million.
Moderna Therapeutics CEO Stephane Bancel

Moderna tumbled in its Wall Street debut after the biggest IPO in biotech history

Moderna Therapeutics started trading Friday in its initial public offering under the ticker "MRNA." The biotech raised more than $600 million.
Moderna Therapeutics CEO Stephane Bancel

Moderna just priced the biggest IPO in biotech history, valuing the startup at $7.5 billion

The biotech Moderna is developing medical treatments based on messenger RNA, though it doesn't have any on the market yet.